Achieve Life Sciences, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Achieve Life Sciences, Inc. (ACHV) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $6.96 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- Achieve Life Sciences, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $6.96M, a 140.82% increase year-over-year.
- Achieve Life Sciences, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was -$685.00K, a 130.69% decline year-over-year.
- Achieve Life Sciences, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $2.34M, a 74.63% increase year-over-year.
- Achieve Life Sciences, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $2.89M, a 98.62% increase year-over-year.
- Achieve Life Sciences, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $8.76M, a 64.53% increase from fiscal 2024.
- Achieve Life Sciences, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $5.33M, a 54.84% increase from fiscal 2023.
- Achieve Life Sciences, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $3.44M, a 5.17% increase from fiscal 2022.
- Achieve Life Sciences, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $3.27M, a 49.52% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $6.96M 10-Q · filed 2026-08-11 | $6.27M derived: sum of 2 quarters · filed 2026-08-11 | |||
| 2026-03-31 | -$685.00K 10-Q · filed 2026-08-11 | ||||
| 2025-12-31 | $8.76M 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | $2.34M 10-Q · filed 2025-11-06 | $5.23M derived: sum of 2 quarters · filed 2026-08-11 | $7.46M derived: sum of 3 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $2.89M 10-Q · filed 2026-08-11 | $5.12M derived: sum of 2 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $2.23M 10-Q · filed 2026-08-11 | ||||
| 2024-12-31 | $5.33M 10-K · filed 2026-03-24 | ||||
| 2024-09-30 | $1.34M 10-Q · filed 2025-11-06 | $2.79M derived: sum of 2 quarters · filed 2025-11-06 | $4.08M derived: sum of 3 quarters · filed 2025-11-06 | ||
| 2024-06-30 | $1.45M 10-Q · filed 2025-11-06 | $2.74M derived: sum of 2 quarters · filed 2025-11-06 | |||
| 2024-03-31 | $1.29M 10-Q · filed 2025-11-06 | ||||
| 2023-12-31 | $3.44M 10-K · filed 2026-03-24 | ||||
| 2023-09-30 | $1.17M 10-Q · filed 2024-11-07 | $2.36M derived: sum of 2 quarters · filed 2024-11-07 | $3.45M derived: sum of 3 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $1.19M 10-Q · filed 2024-11-07 | $2.27M derived: sum of 2 quarters · filed 2024-11-07 | |||
| 2023-03-31 | $1.08M 10-Q · filed 2024-11-07 | ||||
| 2022-12-31 | $3.27M 10-K · filed 2025-03-11 | ||||
| 2022-09-30 | $829.00K 10-Q · filed 2023-11-09 | $1.67M derived: sum of 2 quarters · filed 2023-11-09 | $2.49M derived: sum of 3 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $840.00K 10-Q · filed 2023-11-09 | $1.66M derived: sum of 2 quarters · filed 2023-11-09 | |||
| 2022-03-31 | $823.00K 10-Q · filed 2023-11-09 | ||||
| 2021-12-31 | $2.19M 10-K · filed 2024-03-28 | ||||
| 2021-09-30 | $530.00K 10-Q · filed 2022-11-14 | $1.15M derived: sum of 2 quarters · filed 2022-11-14 | $1.69M derived: sum of 3 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $621.00K 10-Q · filed 2022-11-14 | $1.16M derived: sum of 2 quarters · filed 2022-11-14 | |||
| 2021-03-31 | $542.00K 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | $1.29M 10-K · filed 2023-03-16 | ||||
| 2020-09-30 | $281.00K 10-Q · filed 2021-11-09 | $589.00K derived: sum of 2 quarters · filed 2021-11-09 | $891.00K derived: sum of 3 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $308.00K 10-Q · filed 2021-11-09 | $610.00K derived: sum of 2 quarters · filed 2021-11-09 | |||
| 2020-03-31 | $302.00K 10-Q · filed 2021-11-09 | ||||
| 2019-12-31 | $1.20M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $310.00K 10-Q · filed 2020-11-12 | $627.00K derived: sum of 2 quarters · filed 2020-11-12 | $917.00K derived: sum of 3 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $317.00K 10-Q · filed 2020-11-12 | $607.00K derived: sum of 2 quarters · filed 2020-11-12 | |||
| 2019-03-31 | $290.00K 10-Q · filed 2020-11-12 | ||||
| 2018-12-31 | $1.20M 10-K · filed 2022-03-10 | $854.00K 10-K · filed 2019-03-14 | |||
| 2018-09-30 | $210.00K 10-Q · filed 2019-11-06 | $407.00K derived: sum of 2 quarters · filed 2019-11-06 | $588.00K derived: sum of 3 quarters · filed 2019-11-06 | ||
| 2018-06-30 | $197.00K 10-Q · filed 2019-11-06 | $378.00K derived: sum of 2 quarters · filed 2019-11-06 | |||
| 2018-03-31 | $181.00K 10-Q · filed 2019-11-06 | ||||
| 2017-12-31 | $348.00K 10-K · filed 2020-03-13 | ||||
| 2016-12-31 | $1.65M 10-K · filed 2017-02-23 | ||||
| 2015-12-31 | $2.33M 10-K · filed 2017-02-23 | ||||
| 2014-12-31 | $3.86M 10-K · filed 2017-02-23 | ||||
| 2013-12-31 | $2.84M 10-K · filed 2016-03-09 | ||||
| 2012-12-31 | $2.17M 10-K · filed 2015-03-26 | ||||
| 2011-12-31 | $1.19M 10-K · filed 2014-03-11 | ||||
| 2010-12-31 | $642.00K 10-K · filed 2013-03-07 | ||||
| 2009-12-31 | $380.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |